Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Grey

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Science (New York, N.Y.)|August 31, 1990
The minimal number of class II MHC-antigen complexes needed for T cell activationS Demotz, H M Grey, A Sette
Seminars in Cancer Biology|December 1, 1995
Epitope selection and development of peptide based vaccines to treat cancerE Celis, A Sette, H M Grey
Biochemistry|February 2, 1971
Structural studies on the duck 5.7S and 7.8S immunoglobulinsB Zimmerman, N Shalatin, H M Grey
The Journal of Clinical Investigation|November 1, 1971
Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemiaH M Grey, E Rabellino, B Pirofsky
Clinical Immunology and Immunopathology|November 1, 1989
Biologic significance and therapeutic implications of antigen/MHC interactionsH M Grey, A Sette, A Lamont
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1974
IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemiaR T Kubo, H M Grey, B Pirofsky
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1979
Heterogeneity of binding of human IgA subclasses to protein AM J Brunda, P Minden, H M Grey
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1970
The cytophilic activity of human immunoglobulinsC Inchley, H M Grey, J W Uhr
Scandinavian Journal of Immunology|January 1, 1976
PHA-induced activation of suppressor cells in normal human peripheral blood lymphocytesJ T Kurnick, C Bell, H M Grey
International Reviews of Immunology|January 1, 1990
Inhibition of antigen presentation in vitro and in vivo by MHC antagonist peptidesA G Lamont, A Sette, H M Grey
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Science (New York, N.Y.)|August 31, 1990
The minimal number of class II MHC-antigen complexes needed for T cell activationS Demotz, H M Grey, A Sette
Seminars in Cancer Biology|December 1, 1995
Epitope selection and development of peptide based vaccines to treat cancerE Celis, A Sette, H M Grey
Biochemistry|February 2, 1971
Structural studies on the duck 5.7S and 7.8S immunoglobulinsB Zimmerman, N Shalatin, H M Grey
The Journal of Clinical Investigation|November 1, 1971
Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemiaH M Grey, E Rabellino, B Pirofsky
Clinical Immunology and Immunopathology|November 1, 1989
Biologic significance and therapeutic implications of antigen/MHC interactionsH M Grey, A Sette, A Lamont
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1974
IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemiaR T Kubo, H M Grey, B Pirofsky
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1979
Heterogeneity of binding of human IgA subclasses to protein AM J Brunda, P Minden, H M Grey
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1970
The cytophilic activity of human immunoglobulinsC Inchley, H M Grey, J W Uhr
Scandinavian Journal of Immunology|January 1, 1976
PHA-induced activation of suppressor cells in normal human peripheral blood lymphocytesJ T Kurnick, C Bell, H M Grey
International Reviews of Immunology|January 1, 1990
Inhibition of antigen presentation in vitro and in vivo by MHC antagonist peptidesA G Lamont, A Sette, H M Grey
Pageof 18